Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 33 entries
Sorted by: Best Match Show Resources per page
[The value of ipsilateral breast tumor recurrence as a quality indicator: hospital variation in the Netherlands].

Nederlands tijdschrift voor geneeskunde

van der Heiden-van der Loo M, Siesling S, Wouters MW, van Dalen T, Rutgers EJ, Peeters PH.
PMID: 26813014
Ned Tijdschr Geneeskd. 2016;160:A9572.

OBJECTIVE: All Dutch hospitals are obliged to report their 5-year ipsilateral breast tumor recurrence (IBTR) rate after breast cancer surgery. Experts decided that these rates should not exceed 5%. This study determined the value of IBTR as an indicator...

Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

Nature communications

Ghoussaini M, Edwards SL, Michailidou K, Nord S, Cowper-Sal Lari R, Desai K, Kar S, Hillman KM, Kaufmann S, Glubb DM, Beesley J, Dennis J, Bolla MK, Wang Q, Dicks E, Guo Q, Schmidt MK, Shah M, Luben R, Brown J, Czene K, Darabi H, Eriksson M, Klevebring D, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Lambrechts D, Thienpont B, Neven P, Wildiers H, Broeks A, Van't Veer LJ, Rutgers EJT, Couch FJ, Olson JE, Hallberg E, Vachon C, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Peto J, Dos-Santos-Silva I, Gibson L, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Hall P, Li J, Liu J, Humphreys K, Kang D, Choi JY, Park SK, Noh DY, Matsuo K, Ito H, Iwata H, Yatabe Y, Guénel P, Truong T, Menegaux F, Sanchez M, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Benitez J, Pilar Zamora M, Perez JIA, Menéndez P, Shu XO, Lu W, Gao YT, Cai Q, Cox A, Cross SS, Reed MWR, Andrulis IL, Knight JA, Glendon G, Tchatchou S, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Lindblom A, Margolin S, Teo SH, Yip CH, Lee DSC, Wong TY, Hooning MJ, Martens JWM, Collée JM, van Deurzen CHM, Hopper JL, Southey MC, Tsimiklis H, Kapuscinski MK, Shen CY, Wu PE, Yu JC, Chen ST, Alnæs GG, Borresen-Dale AL, Giles GG, Milne RL, McLean C, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Hartman M, Miao H, Buhari SABS, Teo YY, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Swerdlow A, Ashworth A, Orr N, Schoemaker MJ, García-Closas M, Figueroa J, Chanock SJ, Lissowska J, Simard J, Goldberg MS, Labrèche F, Dumont M, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Brauch H, Brüning T, Koto YD, Radice P, Peterlongo P, Bonanni B, Volorio S, Dörk T, Bogdanova NV, Helbig S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Devilee P, Tollenaar RAEM, Seynaeve C, Van Asperen CJ, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Hamann U, Torres D, Zheng W, Long J, Anton-Culver H, Neuhausen SL, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, González-Neira A, Pita G, Rosario Alonso M, Álvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, de Santiago I, Carroll J, Caldas C, Brown MA, Lupien M, Kristensen VN, Pharoah PDP, Chenevix-Trench G, French JD, Easton DF, Dunning AM.
PMID: 29633761
Nat Commun. 2018 Apr 10;9:16193. doi: 10.1038/ncomms16193.

This corrects the article DOI: 10.1038/ncomms5999.

Current approach of the axilla in patients with early-stage breast cancer.

Lancet (London, England)

Mamounas EP, Kuehn T, Rutgers EJT, von Minckwitz G.
PMID: 28818521
Lancet. 2017 Aug 14; doi: 10.1016/S0140-6736(17)31451-4. Epub 2017 Aug 14.

The surgical approach of the axilla in patients with early-stage breast cancer has witnessed considerable evolution during the past 25 years. The previously undisputed gold standard of axillary-lymph-node dissection for staging has now been replaced by sentinel-lymph-node biopsy for...

Outcome without any adjuvant systemic treatment in stage I ER+/HER2- breast cancer patients included in the MINDACT trial.

Annals of oncology : official journal of the European Society for Medical Oncology

Cardozo JMNL, Byng D, Drukker CA, Schmidt MK, Binuya MA, Veer LJV', Cardoso F, Piccart M, Smorenburg CH, Poncet C, Rutgers EJT.
PMID: 34861376
Ann Oncol. 2021 Nov 30; doi: 10.1016/j.annonc.2021.11.014. Epub 2021 Nov 30.

BACKGROUND: Adjuvant systemic treatments (AST) reduce mortality, but have associated short- and long-term toxicities. Careful selection of patients likely to benefit from AST is needed. We evaluated outcome of low-risk breast cancer patients of the EORTC 10041/BIG 3-04 MINDACT...

Post-operative re-irradiation with hyperthermia in locoregional breast cancer recurrence: Temperature matters.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Bakker A, Tello Valverde CP, van Tienhoven G, Kolff MW, Kok HP, Slotman BJ, Konings IRHM, Oei AL, Oldenburg HSA, Rutgers EJT, Rasch CRN, van den Bongard HJGD, Crezee H.
PMID: 34973278
Radiother Oncol. 2021 Dec 29;167:149-157. doi: 10.1016/j.radonc.2021.12.036. Epub 2021 Dec 29.

PURPOSE: To investigate the impact of hyperthermia thermal dose (TD) on locoregional control (LRC), overall survival (OS) and toxicity in locoregional recurrent breast cancer patients treated with postoperative re-irradiation and hyperthermia.METHODS: In this retrospective study, 112 women with resected...

Combined skin-sparing mastectomy and immediate implant-based breast reconstruction: Outcome following mantle field irradiation versus outcome following whole-breast irradiation.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS

van Huizum MA, Hage JJ, Russell NS, Rutgers E, Woerdeman LAE.
PMID: 34483080
J Plast Reconstr Aesthet Surg. 2021 Aug 18; doi: 10.1016/j.bjps.2021.08.003. Epub 2021 Aug 18.

BACKGROUND: Mastectomy may be needed in the context of previous radiotherapy in cases of breast carcinoma following mantle field radiotherapy for Hodgkin lymphoma or in cases of local relapse or second primary tumours after breast conserving therapy including whole-breast...

Outcome without any adjuvant systemic treatment in stage I ER+/HER2- breast cancer patients included in the MINDACT trial.

Annals of oncology : official journal of the European Society for Medical Oncology

Lopes Cardozo JMN, Byng D, Drukker CA, Schmidt MK, Binuya MA, van 't Veer LJ, Cardoso F, Piccart M, Smorenburg CH, Poncet C, Rutgers EJT.
PMID: 34861376
Ann Oncol. 2021 Dec 01; doi: 10.1016/j.annonc.2021.11.014. Epub 2021 Dec 01.

BACKGROUND: Adjuvant systemic treatments (AST) reduce mortality, but have associated short- and long-term toxicities. Careful selection of patients likely to benefit from AST is needed. We evaluated outcome of low-risk breast cancer patients of the EORTC 10041/BIG 3-04 MINDACT...

Molecular Imaging in Breast Cancer: From Whole-Body PET/CT to Dedicated Breast PET.

Journal of oncology

Koolen BB, Vogel WV, Vrancken Peeters MJ, Loo CE, Rutgers EJ, Valdés Olmos RA.
PMID: 22848217
J Oncol. 2012;2012:438647. doi: 10.1155/2012/438647. Epub 2012 Jul 10.

Positron emission tomography (PET), with or without integrated computed tomography (CT), using 18F-fluorodeoxyglucose (FDG) is based on the principle of elevated glucose metabolism in malignant tumors, and its use in breast cancer patients is frequently being investigated. It has...

Impact of margin status and lymphadenectomy on clinical outcomes in resected pancreatic adenocarcinoma: implications for adjuvant radiotherapy.

Journal of gastrointestinal oncology

Osipov A, Naziri J, Hendifar A, Dhall D, Rutgers JK, Chopra S, Li Q, Tighiouart M, Annamalai A, Nissen NN, Tuli R.
PMID: 27034792
J Gastrointest Oncol. 2016 Apr;7(2):239-47. doi: 10.3978/j.issn.2078-6891.2015.109.

BACKGROUND: Adjuvant chemoradiotherapy (CRT) in the treatment of pancreatic ductal adenocarcinoma (PDA) is controversial. Minimal data exists regarding the clinical significance of margin clearance distance and lymph node (LN) parameters, such as extent of dissection and LN ratio. We...

Intergeneric transfer of a partial genome and direct production of monosomic addition plants by microprotoplast fusion.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik

Ramulu KS, Dijkhuis P, Rutgers E, Blaas J, Krens FA, Verbeek WH, Colijn-Hooymans CM, Verhoeven HA.
PMID: 24166252
Theor Appl Genet. 1996 Mar;92(3):316-25. doi: 10.1007/BF00223674.

Results are reported on the transfer of single, specific chromosomes carrying kanamycin resistance (Kan(R)) and β-glucuronidase (GUS) traits from a transformed donor line of potato (Solanum tuberosum) to a recipient line of the tomato species Lycopersicon peruvianum through microprotoplast...

Comparison of endoscopic ultrasound guided fine needle aspiration and PET/CT in preoperative diagnosis of pancreatic adenocarcinoma.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Lai JP, Yue Y, Zhang W, Zhou Y, Frishberg D, Jamil LH, Mirocha JM, Guindi M, Balzer B, Bose S, Cao D, Lo S, Fan X, Rutgers JK.
PMID: 28501471
Pancreatology. 2017 Jul - Aug;17(4):617-622. doi: 10.1016/j.pan.2017.04.008. Epub 2017 Apr 13.

BACKGROUND: Endoscopic ultrasound guided fine needle aspiration (EUS-FNA) is the procedure of choice to investigate and sample pancreatic masses for the preoperative diagnosis of pancreatic ductal adenocarcinoma (PDAC). The role of METHODS: Preoperative evaluation by PET/CT and EUS-FNA was...

Reply to letter from Suguatti et al.

European journal of cancer (Oxford, England : 1990)

Cataliotti L, Marotti L, Beishon M, Costa A, Knox S, Rutgers E, Cardoso F.
PMID: 28943205
Eur J Cancer. 2017 Dec;87:201-202. doi: 10.1016/j.ejca.2017.06.044. Epub 2017 Sep 21.

No abstract available.

Showing 1 to 12 of 33 entries